First results from POSITIVE study: Young women with breast can safely have a baby BIGagainstBC 6 December 2022
OlympiA trial – olaparib reduces risk of death by 32% in patients with a specific breast cancer profile Monet St Juste 23 September 2022
Eight-year data from APHINITY study show Roche’s Perjeta-based regimen continues to reduce the risk of disease returning for people with HER2-positive early breast cancer Monet St Juste 23 September 2022